Ventripoint Diagnostics Reveals New Convertible Debenture Offering
Company Announcements

Ventripoint Diagnostics Reveals New Convertible Debenture Offering

Story Highlights

VentriPoint Diagnostics (TSE:VPT) has released an update.

Ventripoint Diagnostics Ltd. has announced a revised non-brokered private placement offering of unsecured convertible debentures worth up to CDN$1,000,000. The debentures, convertible at various price points over the years, aim to attract investors with a 10% annual interest rate and potential automatic conversion into common shares under specific conditions.

For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskVentripoint Earns EU CE Mark for AI Heart Tech
TipRanks Canadian Auto-Generated NewsdeskVentripoint Diagnostics Closes First Private Placement Tranche
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App